Procter & Gamble Health Share Price

Procter & Gamble Health Share Price

NSE: PGHL
|
Pharmaceuticals
|
S Cap
₹ 5,757.50
+₹88.00 (1.55%)
1D
Last updated 03 Sep, 2026, 15:50 IST

Procter & Gamble Health Share Price Today

As of 3 Sep 2026, Procter & Gamble Health share price is ₹5,757.50. The stock opened at ₹5,680.00, compared to its previous close of ₹5,669.50. During today's trading session, Procter & Gamble Health share price moved in the range of ₹5,646.00 to ₹5,773.00, with an average price of ₹5,709.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹4,707.00 and a high of ₹6,975.00. On the performance front, Procter & Gamble Health share price has increased by 13.67% over the last six months and is down 10.46% on a year-on-year basis.

₹5,646.00
1.55% up today
₹5,773.00
1D LOW
1D HIGH

Procter & Gamble Health Returns Calculator

Circuit
L
H
₹4,536.00
₹6,803.00
52-week
L
H
₹4,707.00
₹6,975.00

About Procter & Gamble Health

Procter & Gamble Health Share Price
ISIN
INE199A01012
Sector Market Cap
₹ 9,426.96 Cr

Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.

Procter & Gamble Health Financial Highlights

  • Revenue: Procter & Gamble Health reported revenue of ₹1,425.31 crore in FY26 vs ₹944.52 crore in FY25. It showed an increase of 50.90% on a yearly basis.
  • Operating Profit: Procter & Gamble Health reported an operating profit of ₹449.86 crore in FY26 vs ₹311.62 crore in FY25. It showed an increase of 44.36% on a year-on-year basis.
  • Net Profit: Procter & Gamble Health reported a net profit of ₹326.91 crore in FY26 vs ₹234.41 crore in FY25. It showed an increase of 39.46% on a yearly basis.

Procter & Gamble Health Quarterly Result Highlights

  • Procter & Gamble Health reported revenue of ₹367.59 crore in Jun 2026, compared with ₹374.45 crore in Mar 2026, representing a decrease of 1.83% on a quarter-on-quarter (QoQ) basis.
  • Procter & Gamble Health reported an operating profit of ₹129.12 crore in Jun 2026, compared with ₹133.21 crore in Mar 2026, representing a decrease of 3.07% on a quarter-on-quarter (QoQ) basis.
  • Procter & Gamble Health reported a profit of ₹96.15 crore in Jun 2026, compared with ₹94.60 crore in Mar 2026, reflecting an increase of 1.64% on a QoQ basis.
  • The earnings per share (EPS) of Procter & Gamble Health stood at ₹141.00 during Jun 2026.
Know more
Promoters
51.82%
FII
6.33%
Other DII
3.39%
Retail and other
29.42%
Mutual funds
9.05%
Foreign institutions - FII
FII shareholding by period
Sep 20257.24%
Dec 20256.97%
Mar 20266.20%
Jun 20266.33%
Mkt Cap Cr
9,426.96
P/E
26.41
P/B
17.97
ROE
62.32%
D/E
0.02
ROCE
84.14%
Div. Yield
3.61%
EPS(TTM)
196.94
Turnover
1.70
EV/EBITDA
18.28
Net Margin
20.86%
Op. Margin
30.24%
ROA
42.42%
Quick Ratio
1.65
Curr. Ratio
2.21
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
P & G Health Ltd has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
P & G Health Ltd appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,833.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,163.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,431.0017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma98,304.7047.546.0311.74%0.3413.13%396.980.04%0.4449.37
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

Procter & Gamble Health Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Jun 2024Jun 2023Jun 2022
Revenue₹934.17₹1,151.26₹1,229.62₹1,114.41
Other Income₹10.35₹15.63₹18.39₹13.19
Total Revenue₹944.52₹1,166.89₹1,248.01₹1,127.60
Total Expenses₹632.90₹873.38₹933.81₹874.23
Profit Before Tax₹311.62₹273.32₹314.20₹253.37
Tax₹77.21₹72.34₹84.73₹60.85
Profit After Tax₹234.41₹200.98₹229.47₹192.52
EPS - Basic₹141.00₹121.00₹138.00₹116.00
EPS - Diluted₹141.00₹121.00₹138.00₹116.00

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Jun 2024Jun 2023
Profit before tax₹449.86₹311.62₹273.32₹314.20
Income before WC changes₹465.04₹323.82₹325.59₹355.69
Change in Assets-₹73.84-₹69.92₹70.57-₹97.15
Change in Liabilities₹50.44-₹3.89-₹82.68₹67.13
Change in WC-₹23.40-₹73.81-₹12.11-₹30.02
Cash flow from Operations₹337.79₹168.69₹228.29₹236.01
Cash flow from Investing₹1.26₹9.59-₹6.87-₹21.50
Cash flow from Financing-₹343.92-₹234.74-₹418.11-₹98.49
Total Cash Flow-₹4.87-₹56.46-₹196.69₹116.02
Cash (Start of the year)₹182.27₹238.73₹435.42₹319.40
Cash (End of the year)₹177.40₹182.27₹238.73₹435.42

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Jun 2024Jun 2023Jun 2022
Non-Current Assets₹267.81₹270.14₹305.09₹280.08
Current Assets₹526.39₹524.22₹796.10₹608.04
Total Assets₹794.20₹794.36₹1,101.19₹888.12
Current Liabilities₹215.31₹218.91₹303.90₹231.90
Net Current Asset₹311.08₹305.31₹492.20₹376.14
Non-Current Liabilities₹41.93₹37.21₹46.40₹39.73
Equity Capital₹536.96₹538.24₹750.89₹616.49
Total Equity & Liabilities₹794.20₹794.36₹1,101.19₹888.12
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
5757.5
25
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 25
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
4
Bullish
2
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
31.5
Neutral
ATR (14)
112.82
Neutral
STOCH(9,6)
10.55
Bullish
STOCH RSI (14)
49.49
Neutral
ADX(9)
44.71
Bearish
UO(9)
39.17
Neutral
ROC(12)
-2.86
Bearish
WillR(14)
-91.45
Bullish
Period
Simple value
Exponential vaue
5D
5721.3
5731.21
10D
5774
5779.29
20D
5860.58
5908.26
50D
6288.69
6063.84
100D
5942.32
5960.3
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L
Compare against other stocks
Procter & Gamble Health Share Price
Procter & Gamble Health
Pharmaceuticals
Add Stock
Add Another

Procter & Gamble Health Share Price FAQs